These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37676831)

  • 1. Association between a network-based physician linchpin score and cancer patient mortality: a SEER-Medicare analysis.
    Moen EL; Schmidt RO; Onega T; Brooks GA; O'Malley AJ
    J Natl Cancer Inst; 2024 Feb; 116(2):230-238. PubMed ID: 37676831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a Novel Network-Based Linchpin Score to Characterize Accessibility to the Oncology Physician Workforce in the United States.
    Moen EL; Brooks GA; O'Malley AJ; Schaefer A; Carlos HA; Onega T
    JAMA Netw Open; 2022 Dec; 5(12):e2245995. PubMed ID: 36525275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in Access to Multidisciplinary Cancer Consultations and Treatment for Patients With Early-Stage Non-Small Cell Lung Cancer: A SEER-Medicare Analysis.
    Liu YC; Schmidt RO; Kapadia NS; Phillips JD; Moen EL
    Int J Radiat Oncol Biol Phys; 2024 Sep; 120(1):102-110. PubMed ID: 38490619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgeon and Care Team Network Measures and Timely Breast Cancer Treatment.
    Ash R; Scodari BT; Schaefer AP; Cornelius SL; Brooks GA; O'Malley AJ; Onega T; Verhoeven DC; Moen EL
    JAMA Netw Open; 2024 Aug; 7(8):e2427451. PubMed ID: 39207756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Referral and treatment patterns among patients with stages III and IV non-small-cell lung cancer.
    Goulart BH; Reyes CM; Fedorenko CR; Mummy DG; Satram-Hoang S; Koepl LM; Blough DK; Ramsey SD
    J Oncol Pract; 2013 Jan; 9(1):42-50. PubMed ID: 23633970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A measure of local uniqueness to identify linchpins in a social network with node attributes.
    Nemesure MD; Schwedhelm TM; Sacerdote S; O'Malley AJ; Rozema LR; Moen EL
    Appl Netw Sci; 2021; 6():. PubMed ID: 34938853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations.
    Williams CD; Alpert N; Redding TS; Bullard AJ; Flores RM; Kelley MJ; Taioli E
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):112-118. PubMed ID: 31624076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
    Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL
    J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary care utilization and colorectal cancer outcomes among Medicare beneficiaries.
    Ferrante JM; McCarthy EP; Gonzalez EC; Lee JH; Chen R; Love-Jackson K; Roetzheim RG
    Arch Intern Med; 2011 Oct; 171(19):1747-57. PubMed ID: 22025432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of US Oncologist Rurality by Practice Setting and Patients Served.
    Cornelius SL; Shaefer AP; Wong SL; Moen EL
    JAMA Netw Open; 2024 Jan; 7(1):e2350504. PubMed ID: 38180759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and Survival of Medicare Beneficiaries with Colorectal Cancer: A Comparative Analysis Between a Rural State Cancer Registry and National Data.
    Rane PB; Madhavan SS; Sambamoorthi U; Sita K; Kurian S; Pan X
    Popul Health Manag; 2017 Feb; 20(1):55-65. PubMed ID: 27419662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between physician characteristics and the use of 21-gene recurrence score genomic testing among Medicare beneficiaries with early-stage breast cancer, 2008-2011.
    Wilson LE; Pollack CE; Greiner MA; Dinan MA
    Breast Cancer Res Treat; 2018 Jul; 170(2):361-371. PubMed ID: 29536319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collaboration Between Surgeons and Medical Oncologists and Outcomes for Patients With Stage III Colon Cancer.
    Hussain T; Chang HY; Veenstra CM; Pollack CE
    J Oncol Pract; 2015 May; 11(3):e388-97. PubMed ID: 25873063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Burden of Medicare Beneficiaries With Stage I Non-Small-Cell Lung Cancer.
    Presley CJ; Soulos PR; Tinetti M; Montori VM; Yu JB; Gross CP
    J Oncol Pract; 2017 Feb; 13(2):e98-e107. PubMed ID: 27997301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: A Medicare SEER cohort analysis.
    Balkrishnan R; Desai RP; Narayan A; Camacho FT; Flausino LE; Chammas R
    Cancer Med; 2021 Aug; 10(15):5347-5357. PubMed ID: 34184420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guideline-concordant timely lung cancer care and prognosis among elderly patients in the United States: A population-based study.
    Nadpara P; Madhavan SS; Tworek C
    Cancer Epidemiol; 2015 Dec; 39(6):1136-44. PubMed ID: 26138902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.
    Erb CT; Su KW; Soulos PR; Tanoue LT; Gross CP
    Lung Cancer; 2016 Sep; 99():200-7. PubMed ID: 27565940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world effectiveness of systemic agents approved for advanced non-small cell lung cancer: a SEER-Medicare analysis.
    Owonikoko TK; Ragin C; Chen Z; Kim S; Behera M; Brandes JC; Saba NF; Pentz R; Ramalingam SS; Khuri FR
    Oncologist; 2013; 18(5):600-10. PubMed ID: 23635558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.